Clinically, SALL4 expression is enriched in combined or mixed HCC–CCA tumors, which display both hepatocytic and CC features reminiscent of bipotential progenitor-like cells such as hepatoblasts and LPCs (18). This evidence concerns the gene SALL4 and hepatocellular carcinoma.